Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Todd Neale

January 19, 2017

News Daily News

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

Caitlin E. Cox

February 16, 2016

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

News Conference News ESC 2012

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Caitlin E. Cox

August 26, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

Advertisement

Radial Access Best for PCI Following Thrombolysis in STEMI

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

FDA approves Repatha to treat certain patients with high cholesterol

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Indirect Comparisons Show Little Difference Among New Anticoagulants

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content